AAP
5
-3
EMC
54
-2
EMR
64
-3
KIM
51
-3
XEL
39
-2
DRI
56
-2
FLR
40
-2
TRV
48
-10
AME
66
-3
PX
62
6
ADM
44
-7
ISRG
66
-2
AZO
43
-5
FOXA
59
-4
RIG
35
-6
FTI
60
-18
LEG
58
-4
EOG
32
-14
TJX
64
-2
URBN
70
-4
AAP
5
-3
EMC
54
-2
EMR
64
-3
KIM
51
-3
XEL
39
-2
DRI
56
-2
FLR
40
-2
TRV
48
-10
AME
66
-3
PX
62
6
ADM
44
-7
ISRG
66
-2
AZO
43
-5
FOXA
59
-4
RIG
35
-6
FTI
60
-18
LEG
58
-4
EOG
32
-14
TJX
64
-2
URBN
70
-4
Financhill
Back

BNY Mellon Ultra Short Income ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
38

BKUI
BNY Mellon Ultra Short Income ETF

Last Price:
$49.86
Seasonality Move:
0.14%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$56.88
Seasonality Move:
16.15%
Sell
38
BNY Mellon Ultra Short Income ETF (BKUI) is a Sell

Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?

  • The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.85. The Score for BKUI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BKUI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.97. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKUI Stock Price Chart

What is BNY Mellon Ultra Short Income ETF's stock price today?

  • The BNY Mellon Ultra Short Income ETF share price today is $49.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKUI is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.

BKUI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 55.1 Buy
Chaikin Money Flow: -3311 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.79 - 49.87) Buy
Bollinger Bands (100): (49.78 - 49.9) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 48.84 Sell
Chaikin Money Flow: -466021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.56 - 56.88) Buy
Bollinger Bands (100): (52.61 - 65.53) Sell

BKUI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.82 Buy
20-day SMA: 49.84 Buy
50-day SMA: 49.85 Buy
200-day SMA: 49.79 Buy
8-day EMA: 49.83 Buy
20-day EMA: 49.83 Buy
50-day EMA: 49.84 Buy
200-day EMA: 49.79 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.98 Sell
20-day SMA: 54.45 Buy
50-day SMA: 60.1 Sell
200-day SMA: 50.92 Buy
8-day EMA: 56.41 Sell
20-day EMA: 56 Sell
50-day EMA: 56.51 Sell
200-day EMA: 37.03 Buy

BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

BNY Mellon Ultra Short Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):